FVIII Inhibitor Plasma (2) Moderate (11-50 BU/ml), lyophilized
Description
Coagulation factor inhibitor plasmas are produced from normal human plasmas from which specific factors have been removed by selective affinity immuno-adsorption and an antibody inhibitory to the specific factor is added to provide neutralizing activity.
Intended use
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.